The identification of genetic events leading to PI3K/mTOR dysregulation together with the remarkable ... Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution.
A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.
A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.
A randomized study has produced some hopeful news for colorectal cancer survivors with an unlikely suspect: the commonly used ...
By interacting with IGF-1 receptors, these peptides might activate signaling cascades such as the PI3K/Akt pathway ... candidates for research into metabolic therapies. The urocortin family of ...
The therapy is a PI3K inhibitor, which selectively targets a type of protein called PI3K. "We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep ...
Targeted Next-Generation Sequencing in Succinate Dehydrogenase–Deficient GI Stromal Tumor Identifies Actionable Alterations in the PI3K/mTOR Pathway This study included 82 patients with ...
Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical ...